Trial intelligence / Profile preview

ACE inhibitor versus diuretic for hypertension in older adults

ACTRN12622000398707Phase 4Completed

Sponsor
High Blood Pressure Research Council of Australia
Start
Jul 1996
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of enalapril in hypertension (HTN) (2 arms), sponsored by High Blood Pressure Research Council of Australia. Primary endpoint: Composite primary outcome: all-cause mortality and cardiovascular events. Started Jul 1996; status: completed.

02

Drugs

enalapril
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on ACTRN12622000398707.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12622000398707.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call